Found: 126
Select item for more details and to access through your institution.
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 782, doi. 10.1007/s10637-017-0463-y
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 12, doi. 10.1007/s10637-014-0163-9
- By:
- Publication type:
- Article
Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 6, p. 1647, doi. 10.1007/s00520-012-1709-z
- By:
- Publication type:
- Article
Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.
- Published in:
- Scientific Reports, 2016, p. 19552, doi. 10.1038/srep19552
- By:
- Publication type:
- Article
Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194730
- By:
- Publication type:
- Article
Prognostic Impact of Longitudinal Monitoring of Radiomic Features in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-45117-y
- By:
- Publication type:
- Article
Edoxaban for the treatment of hypercoagulability and cerebral thromboembolism associated with cancer: A randomized clinical trial of biomarker targets.
- Published in:
- International Journal of Stroke, 2024, v. 19, n. 6, p. 645, doi. 10.1177/17474930241239266
- By:
- Publication type:
- Article
Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR.
- Published in:
- Journal of Neuro-Oncology, 2020, v. 149, n. 2, p. 367, doi. 10.1007/s11060-020-03617-2
- By:
- Publication type:
- Article
Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 125, n. 2, p. 331, doi. 10.1007/s11060-015-1915-x
- By:
- Publication type:
- Article
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 10, p. 1679, doi. 10.1038/s41416-024-02615-9
- By:
- Publication type:
- Article
Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer.
- Published in:
- PLoS Genetics, 2015, v. 11, n. 8, p. 1, doi. 10.1371/journal.pgen.1005467
- By:
- Publication type:
- Article
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.
- Published in:
- Oncology, 2022, v. 100, n. 4, p. 228, doi. 10.1159/000516813
- By:
- Publication type:
- Article
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
- By:
- Publication type:
- Article
Reappraisal of KIT mutation in adenoid cystic carcinomas of the salivary gland.
- Published in:
- Journal of Oral Pathology & Medicine, 2012, v. 41, n. 5, p. 415, doi. 10.1111/j.1600-0714.2011.01105.x
- By:
- Publication type:
- Article
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274830
- By:
- Publication type:
- Article
Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Utility of positron emission–computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2020, v. 58, n. 5, p. 1019, doi. 10.1093/ejcts/ezaa181
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2459, doi. 10.1007/s00432-021-03527-4
- By:
- Publication type:
- Article
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 12, p. 3359, doi. 10.1007/s00432-020-03316-5
- By:
- Publication type:
- Article
Correction to: Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1341, doi. 10.1007/s00432-019-02889-0
- By:
- Publication type:
- Article
Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 702, doi. 10.1634/theoncologist.2013-0419
- By:
- Publication type:
- Article
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
- By:
- Publication type:
- Article
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
- Published in:
- 2017
- By:
- Publication type:
- journal article
PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 7, p. 2352, doi. 10.1002/cam4.2868
- By:
- Publication type:
- Article
Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70168-x
- By:
- Publication type:
- Article
Predictive and Prognostic Value of <sup>18</sup>F-fluorodeoxyglucose Uptake Combined with Thymidylate Synthase Expression in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48674-4
- By:
- Publication type:
- Article
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 4, p. 956, doi. 10.1002/eji.202048966
- By:
- Publication type:
- Article
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 11, p. 1810, doi. 10.1002/eji.202048534
- By:
- Publication type:
- Article
Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088598
- By:
- Publication type:
- Article
Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064816
- By:
- Publication type:
- Article
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1693, doi. 10.1002/cncr.35175
- By:
- Publication type:
- Article
Biomarker‐driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 4, p. 541, doi. 10.1002/cncr.35059
- By:
- Publication type:
- Article
A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 19, p. 2966, doi. 10.1002/cncr.34892
- By:
- Publication type:
- Article
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 11, p. 2148, doi. 10.1002/cncr.34176
- By:
- Publication type:
- Article
Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real‐world data (KCSG LU20‐11)
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 4, p. 778, doi. 10.1002/cncr.33984
- By:
- Publication type:
- Article
High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 16, p. 3019, doi. 10.1002/cncr.33571
- By:
- Publication type:
- Article
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article